“Since the late 1980s, doctors have been able to detect most prostate cancers using a simple and inexpensive blood test, called P.S.A., that identifies proteins called prostate-specific antigens. The test revolutionized how prostate cancer is diagnosed, allowing doctors to spot it when it is most treatable. By 2021, nearly 98 percent of prostate cancer patients were still alive at least five years after diagnosis.

Traditional treatments for prostate cancer, including radiation therapy and a surgery to remove the entire gland — have long been effective but often come with life-altering costs.

Today, however, new technologies and treatment methods are expanding men’s options.”

From New York Times.